<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: BIZZARI JEAN%2DPIERRE -->
          <cik>0001630914</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001771910</issuerCik>
      <issuerName>ADC Therapeutics SA</issuerName>
      <secFileNumber>001-39071</secFileNumber>
      <issuerAddress>
        <com:street1>430 Mountain Ave Suite 404</com:street1>
        <com:city>New Providence</com:city>
        <com:stateOrCountry>NJ</com:stateOrCountry>
        <com:zipCode>07974</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>908-440-7732</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Jean Bizzari</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Morgan Stanley</name>
        <address>
          <com:street1>1 New York Plaza</com:street1>
          <com:street2>38th Floor</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10004</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>6995</noOfUnitsSold>
      <aggregateMarketValue>20215.55</aggregateMarketValue>
      <noOfUnitsOutstanding>79502</noOfUnitsOutstanding>
      <approxSaleDate>06/17/2024</approxSaleDate>
      <securitiesExchangeName>NYSE</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <acquiredDate>06/14/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Vesting of Restricted Share Unit Grant</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ADC Therapeutics SA</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>20000</amountOfSecuritiesAcquired>
      <paymentDate>06/14/2024</paymentDate>
      <natureOfPayment>Vesting of Restricted Stock Unit Grant</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>The Reporting Person is selling the securities set forth herein pursuant to an automatic "sell to cover" transaction that did not represent a discretionary trade by the Reporting Person in order to pay the tax liability arising from the vesting and settlement of restricted share units.</remarks>
    <noticeSignature>
      <noticeDate>06/17/2024</noticeDate>
      <signature>/s/ Jean Bizzari</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
